Dr. Mohammed Ismail, MD

Dr. Ismail practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Ismail's NPI, 1053774521, was assigned on April 1, 2016. Dr. Ismail holds New Mexico license MD2022-1439.

Dr. Ismail's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Ismail's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Ismail is also affiliated with Presbyterian Hospital. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Ismail to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ismail practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ismail's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Ismail's licenses on file in 2 states: New Mexico and Michigan.

CMS data shows 180 Medicare services from Dr. Ismail across 6 procedure codes in 2024, for 136 Medicare patients. Medicare paid $24,019 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Ismail in 2026. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ismail's median patient age at 70, with 52% women.

In 2026, Dr. Ismail wrote 84 Medicare Part D claims for 26 patients. 95% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $372 in total drug cost. In 2020, CMS named 121 claims across 8 drugs.

Dr. Ismail accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ismail as offering telehealth.

Dmand AI links 1 paper to Dr. Ismail. Dr. Ismail's most frequent co-authors are Jess Wallace Brallier, MD, Patrick J. McCormick, MD and Joshua Samuel Mincer, MD, PhD.

CMS Open Payments shows 85 general payments to Dr. Ismail from 14 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 58% of the total. Penumbra, Inc. paid the most, $3,829.